pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Trikafta · news · pharmadog
← back to Trikafta
News mentioning Trikafta
11
stories
12d
ReCode CEO Suliman leaves cystic fibrosis mission in mentee’s hands
biospace
20d
Sionna lays off 46% of workforce in strategic shift after cystic fibrosis trial fail
fiercebiotech
Aug 25, 26
With mRNA back in the spotlight, tRNA shows potential to treat genetic disease
fiercebiotech
Aug 25, 26
STAT+: Comments on OMB research rule mysteriously removed from federal website
stat
Aug 10, 26
Sionna cystic fibrosis drug fails key trial, removing threat to Vertex
biopharma dive
Aug 10, 26
Sionna’s cystic fibrosis failure is a windfall for Vertex’s blockbuster franchise
biospace
Aug 10, 26
STAT+: Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial
stat
Aug 10, 26
Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for Vertex
fiercebiotech
Aug 4, 26
Vertex’s biggest overhang: a rival 50 times smaller
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
May 5, 26
Vertex earnings get muted investor response
biopharma dive
